Dr. Van Cott is an expert coagulation pathology specialist. Her continuous contributions to the advancement of laboratory guidelines and standards are recognized by the CAP, NASCOLA, CLSI, and THSNA organizations.
Elizabeth Van Cott, MD is Director of the Coagulation Laboratory, and Medical Director of the Core Laboratory at Massachusetts General Hospital. She is past president of the North American Specialized Coagulation Laboratory Association (NASCOLA), and is chair of the Proficiency Testing/External Quality Assessment program. She is an advisor for the Area Committee on Hematology for the Clinical and Laboratory Standards Institute (CLSI), and contributes to writing coagulation laboratory guidelines for CLSI. Dr. Van Cott is an inaugural member of the Standards Committee of the College of American Pathologists (CAP), and was a committee member of the Coagulation Resource Committee for six years. She is an inaugural director on the board of the Thrombosis and Hemostasis Societies of North America (THSNA) and is still a director. Dr. Van Cott was an invited expert at two recent CAP consensus conferences on coagulation, which generated national consensus guidelines for laboratory monitoring of anticoagulant therapy, and thrombophilia. She has over 100 publications on coagulation, and is an editor or editorial board member of multiple journals.
Research interests include:
Clinically-oriented studies in thrombosis and hemostasis
Research is focused on coagulation, in particular, diagnostic coagulation testing and heparin-induced thrombocytopenia (HIT), including new anticoagulants for the treatment of HIT